Outlook Therapeutics
OTLK
$8.68
Share price
-2.69%
Change (1 day)
641.88%
Change (1 year)
Categories
Outlook Therapeutics (OTLK) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $46.02 M
According to Outlook Therapeutics 's latest financial reports the company's total liabilities are $46.02 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Outlook Therapeutics - Total liabilities on balance sheet (from 2015 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-09-30 | $46.73 M | 136.16% |
| 2022-09-30 | $19.79 M | 8.72% |
| 2021-09-30 | $18.2 M | 7.68% |
| 2020-09-30 | $16.9 M | -39.41% |
| 2019-09-30 | $27.9 M | -35.25% |
| 2018-09-30 | $43.09 M | -16.26% |
| 2017-09-30 | $51.46 M | 68.29% |
| 2016-09-30 | $30.57 M | -52.42% |
| 2015-09-30 | $64.26 M | 0% |
| 2014-09-30 | $64.26 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | $2.69 M | -94.14% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $0.12 B | 165.07% | 🇬🇧 UK |
 Novavax NVAX | $2.51 B | 5,362.76% | 🇺🇸 USA |
 Novocure
NVCR | $0.78 B | 1,602.50% | Jersey |